Atlas Trials

A New Treatment Approach for Major Depressive Disorder Based Upon Targeting Monoamine Oxidase A (MAO-A)

Clinical trial NCT02269540 · COMPLETED

Trial details

NCT number
NCT02269540
Sponsor
Centre for Addiction and Mental Health
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2014-10-01
Primary completion
2018-06-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.